Theileria-transformed bovine leukocytes have cancer hallmarks

Trends in Parasitology

Volumn 31, Issue 7, 2015, Pages 306-314

  Tretina, Kyle ^a   Gotia, Hanzel T ^a   Mann, David J ^b   Silva, Joana C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Cellular proliferation; East Coast fever; Hallmarks; Theileria

Indexed keywords

APICOMPLEXA; BOVINE; CANCER CELL; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; ENERGY TRANSFER; HOST CELL; HOST PARASITE INTERACTION; IMMUNE EVASION; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE; MULTIGENE FAMILY; NONHUMAN; PATHOGENESIS; PHENOTYPE; REVIEW; RUMINANT; SIGNAL TRANSDUCTION; THEILERIA; THEILERIA ANNULATA; THEILERIA PARVA; ANIMAL; NEOPLASMS; PARASITOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; THEILERIASIS;

BOVINAE; IXODIDA; THEILERIA; THEILERIA ANNULATA; THEILERIA PARVA;

ANIMALS; CATTLE; LEUKOCYTES; NEOPLASMS; THEILERIA; THEILERIASIS;

EID: 84937514697     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.04.001     Document Type: Review

References (99)

1. Adl S.M., et al. Diversity, nomenclature, and taxonomy of protists. Syst. Biol. 2007, 56:684-689.
2. Vollmer D. Enhancing the Effectiveness of Sustainability Partnerships Summary of a Workshop 2009, The National Academies Press.
3. World Livestock 2011 - Livestock in Food Security 2011, Food and Agriculture Organization. A. McLeod (Ed.).
4. Shaw M.K. The same but different: the biology of Theileria sporozoite entry into bovine cells. Int. J. Parasitol. 1997, 27:457-474.
5. Von Schubert C., et al. The transforming parasite Theileria co-opts host cell mitotic and central spindles to persist in continuously dividing cells. PLoS Biol. 2010, 8:e1000499.
6. Sivakumar T., et al. Evolution and genetic diversity of Theileria. Infect. Genet. Evol. 2014, 27C:250-263.
7. Spooner R.L., et al. Theileria annulata and T. parva infect and transform different bovine mononuclear cells. Immunology 1989, 66:284-288.
8. Gardner M.J., et al. Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes. Science 2005, 309:134-137.
9. Hayashida K., et al. Comparative genome analysis of three eukaryotic parasites with differing abilities to transform leukocytes reveals key mediators of Theileria-induced leukocyte transformation. MBio 2012, 3:e00204-e212.
10. Shiels B., et al. Alteration of host cell phenotype by Theileria annulata and Theileria parva: mining for manipulators in the parasite genomes. Int. J. Parasitol. 2006, 36:9-21.
11. Grootenhuis J.G., et al. Infection of African buffalo (Syncerus caffer) and cattle with Theileria parva lawrencei after serial passage in cattle. Res. Vet. Sci. 1987, 42:326-330.
12. Oryan A., et al. Clinicopathological findings of a natural outbreak of Theileria annulata in cattle: an emerging disease in southern Iran. Parasitol. Res. 2013, 112:123-127.
13. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
14. Whitfield M.L., et al. Common markers of proliferation. Nat. Rev. Cancer 2006, 6:99-106.
15. Dobbelaere D.A.E., Küenzi P. The strategies of the Theileria parasite: A new twist in host-pathogen interactions. Curr. Opin. Immunol. 2004, 16:524-530.
16. McKeever D.J. Live immunisation against Theileria parva: containing or spreading the disease?. Trends Parasitol. 2007, 23:565-568.
17. Reddel R.R. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000, 21:477-484.
18. Hayashida K., et al. MDM2 regulates a novel form of incomplete neoplastic transformation of Theileria parva infected lymphocytes. Exp. Mol. Pathol. 2013, 94:228-238.
19. Marsolier J., et al. OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes. PLoS Pathog. 2013, 9:e1003222.
20. Frauwirth K.A., Thompson C.B. Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest. 2002, 109:295-299.
21. Dobbelaere D.A., et al. Theileria parva infection induces autocrine growth of bovine lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:4730-4734.
22. Shayan P., et al. Is interleukin 2 necessary for the autocrine proliferation of Theileria-infected bovine cells?. Parasitol. Res. 1999, 85:409-412.
23. Demartini J.C., Baldwin C.L. Effects of gamma interferon, tumor necrosis factor alpha, and interleukin-2 on infection and proliferation of Theileria parva-infected vovine lymphoblasts and production of interferon by parasitized Cells. Infect. Immun. 1991, 59:4540-4546.
24. Brown W.C., Grab D.J. Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells. J. Immunol. 1985, 135:3184-3190.
25. Ahmed J.S., et al. The role of interleukin 2 (IL 2) in the proliferation of Theileria annulata-infected bovine lymphocytes. Parasitol. Res. 1987, 73:524-526.
26. Sager H., et al. Interferon production by Theileria annulata-transformed cell lines is restricted to the beta family. Parasite Immunol. 1998, 20:175-182.
27. Ma M., Baumgartner M. Intracellular Theileria annulata promote invasive cell motility through kinase regulation of the host actin cytoskeleton. PLoS Pathog. 2014, 10:e1004003.
28. Guergnon J., et al. A tumour necrosis factor alpha autocrine loop contributes to proliferation and nuclear factor-κB activation of Theileria parva-transformed B cells. Cell. Microbiol. 2003, 5:709-716.
29. Dobbelaere D.A., Rottenberg S. Theileria-induced leukocyte transformation. Curr. Opin. Microbiol. 2003, 6:377-382.
30. Marsolier J., et al. Theileria parasites secrete a prolyl isomerase to transform host leukocytes. Nature 2015, 520:378-382.
31. Goddeeris B., Morrison W. Techniques for the generation, cloning, and characterization of bovine cytotoxic T cells specific for the protozoan Theileria parva. J. Tissue Cult. Methods 1988, 11:101-110.
32. Ghosh A., et al. Telomerase directly regulates NF-kappaB-dependent transcription. Nat. Cell Biol. 2012, 14:1270-1281.
33. Harley C.B. Telomerase and cancer therapeutics. Nat. Rev. Cancer 2008, 8:167-179.
34. Kinnaird J.H., et al. A bovine lymphosarcoma cell line infected with Theileria annulata exhibits an irreversible reconfiguration of host cell gene expression. PLoS ONE 2013, 8:e66833.
35. Durrani Z., et al. Modulation of activation-associated host cell gene expression by the apicomplexan parasite Theileria annulata. Cell Microbiol. 2012, 14:1434-1454.
36. Irvin A.D., Mwamachi D.M. Clinical and diagnostic features of East Coast fever (Theileria parva) infection of cattle. Vet. Rec. 1983, 113:192-198.
37. Ma M., Baumgartner M. Filopodia and membrane blebs drive efficient matrix invasion of macrophages transformed by the intracellular parasite Theileria annulata. PLoS ONE 2013, 8:e75577.
38. Cock-Rada A.M., et al. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. Cancer Res. 2012, 72:810-820.
39. Chaussepied M., et al. TGF-b2 induction regulates invasiveness of Theileria-transformed leukocytes and disease susceptibility. PLoS Pathog. 2010, 6:e1001197.
40. Schoumacher M., et al. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J. Cell Biol. 2010, 189:541-556.
41. Woods K.L., et al. Recruitment of EB1, a master regulator of microtubule dynamics, to the surface of the Theileria annulata schizont. PLoS Pathog. 2013, 9:e1003346.
42. Schneider I., et al. Identification, molecular characterization and subcellular localization of a Theileria annulata parasite protein secreted into the host cell cytoplasm. Parasitol. Res. 2007, 101:1471-1482.
43. Xue G., et al. Characterisation of gp34, a GPI-anchored protein expressed by schizonts of Theileria parva and T. annulata. Mol. Biochem. Parasitol. 2010, 172:113-120.
44. Smith S.C., Theodorescu D. Learning therapeutic lessons from metastasis suppressor proteins. Nat. Rev. Cancer 2009, 9:253-264.
45. Jensen K., et al. Differences in the transcriptional responses induced by Theileria annulata infection in bovine monocytes derived from resistant and susceptible cattle breeds. Int. J. Parasitol. 2008, 38:313-325.
46. MacIver N.J., et al. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013, 31:259-283.
47. Salcedo-Sora J.E., et al. The proliferating cell hypothesis: a metabolic framework for Plasmodium growth and development. Trends Parasitol. 2014, 30:170-175.
48. Chaudhary K., Roos D.S. Protozoan genomics for drug discovery. Nat. Biotechnol. 2005, 23:1089-1091.
49. Upadhyay M., et al. The Warburg effect: insights from the past decade. Pharmacol. Ther. 2013, 137:318-330.
50. Metheni M., et al. Microreview HIF-1α induction, proliferation and glycolysis of Theileria-infected leukocytes. Cell. Microbiol. 2015, 17:467-472.
51. Medjkane S., Weitzman J.B. A reversible Warburg effect is induced by Theileria parasites to transform host leukocytes. Cell Cycle 2013, 12:2167-2168.
52. 2 type oxidative stress regulates virulence of Theileria-transformed leukocytes. Cell. Microbiol. 2014, 16:269-279.
53. Cairns R.A., et al. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
54. Mathew R., et al. Role of autophagy in cancer. Nat. Rev. Cancer 2007, 7:961-967.
55. Duszenko M., et al. Autophagy in protists. Autophagy 2011, 7:127-158.
56. Graumann K., et al. Mammalian apoptotic signalling pathways: multiple targets of protozoan parasites to activate or deactivate host cell death. Microbes Infect. 2009, 11:1079-1087.
57. Heussler V.T., et al. Hijacking of host cell IKK signalosomes by the transforming parasite Theileria. Science 2002, 298:1033-1036.
58. Dessauge F., et al. c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes. Oncogene 2005, 24:1075-1083.
59. Haller D., et al. Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria. Oncogene 2010, 29:3079-3086.
60. Kuenzi P., et al. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis. J. Immunol. 2003, 171:1224-1231.
61. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2002, 2:401-409.
62. Guergnon J., et al. Apoptosis of Theileria-infected lymphocytes induced upon parasite death involves activation of caspases 9 and 3. Biochimie 2003, 85:771-776.
63. Koup R.A., Douek D.C. Vaccine design for CD8 T lymphocyte responses. Cold Spring Harb. Perspect. Med. 2011, 1:a007252.
64. Radley D.E., et al. East Coast fever: challenge if immunised cattle by prolonged exposure to infected ticks. Vet. Rec. 1975, 96:525-527.
65. + fraction of responding efferent lymph. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:1959-1963.
66. Conze G., et al. Evidence for strain specificity in cytotoxic T-lymphocyte-mediated, major histocompatibility complex class I-dependent killing of Theileria annulata-infected cells. Parasitol. Res. 1998, 84:593-595.
67. + T-cell responses to Theileria parva are preferentially directed to a single dominant antigen: Implications for parasite strain-specific immunity. Eur. J. Immunol. 2009, 39:2459-2469.
68. + T cell response by natural variants of an immunodominant epitope from Theileria parva is predominantly due to loss of TCR recognition. J. Immunol. 2011, 187:5910-5920.
69. Jensen K., et al. The protozoan parasite Theileria annulata alters the differentiation state of the infected macrophage and suppresses musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors. Int. J. Parasitol. 2009, 39:1099-1108.
70. Campbell J.D.M., et al. Parasite-mediated steps in immune response failure during primary Theileria annulata infection. Trop. Anim. Health Prod. 1997, 29:133-135.
71. Ahmed J.S., et al. Review: Theileria schizonts induce fundamental alterations in their host cells. Parasitol. Res. 1999, 85:527-538.
72. Campbel J., Spooner R. Macrophages behaving badly: infected cells and subversion of immune responses to Theileria annulata. Parasitol. Today 1999, 15:10-16.
73. Campbell J.D., et al. A non-protective T helper 1 response against the intra-macrophage protozoan Theileria annulata. Clin. Exp. Immunol. 1997, 108:463-470.
74. Hart J., et al. Theileria annulata-transformed cell lines are efficient antigen-presenting cells for in vitro analysis of CD8 T cell responses to bovine herpesvirus-1. Vet. Res. 2011, 42:119.
75. Campbell J.D., et al. Theileria annulata induces abberrant T cell activation in vitro and in vivo. Clin. Exp. Immunol. 1995, 99:203-210.
76. + T cells are associated with a lack of cytotoxic T cell responses during Theileria annulata infection. Clin. Exp. Immunol. 1999, 116:316-321.
77. Shaw M.K., et al. MHC class I molecules are an essential cell surface component involved in Theileria parva sporozoite binding to bovine lymphocytes. J. Cell Sci. 1995, 108:1587-1596.
78. Zhou F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol. 2009, 28:239-260.
79. McKeever D.J., et al. In vitro infection with Theileria parva is associated with IL10 expression in all bovine lymphocyte lineages. Parasite Immunol. 1997, 19:319-324.
80. DeMartini J.C., et al. Differential in vitro and in vivo expression of MHC class II antigens in bovine lymphocytes infected by Theileria parva. Vet. Immunol. Immunopathol. 1993, 35:253-273.
81. Ryan S.O., Cobb B.A. Roles for major histocompatibility complex glycosylation in immune function. Semin. Immunopathol. 2012, 34:425-441.
82. Morrison W.I., et al. Pathogenicity of Theileria parva is influenced by the host cell type infected by the parasite. Infect. Immun. 1996, 64:557-562.
83. Phillips R.E. Immunology taught by Darwin. Nat. Immunol. 2002, 3:987-989.
84. Seluanov A., et al. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19352-19357.
85. Dobbelaere D.A., et al. Lymphocytes infected with Theileria parva require both cell-cell contact and growth factor to proliferate. Eur. J. Immunol. 1991, 21:89-95.
86. Massagué J. TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 2012, 13:616-630.
87. Haidar M., et al. TGF-β2 promotes transcription of COX2 and EP4 leading to a PGE2-driven auto-stimulatory loop that enhances virulence of Theileria-transformed macrophages. Infect. Immun. 2015, 83:1869-1880.
88. Vogelstein B., Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 2004, 10:789-799.
89. Weitzman M.D., Weitzman J.B. What's the damage? The impact of pathogens on pathways that maintain host genome integrity. Cell Host Microbe 2014, 15:283-294.
90. Tili E., et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4908-4913.
91. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000, 16:168-174.
92. Robertson K.D. DNA methylation, methyltransferases, and cancer. Oncogene 2001, 20:3139-3155.
93. Brodsky I.E., Medzhitov R. Targeting of immune signalling networks by bacterial pathogens. Nat. Cell Biol. 2009, 11:521-526.
94. Weir W., et al. Evolution and diversity of secretome genes in the apicomplexan parasite Theileria annulata. BMC Genomics 2010, 11:42.
95. Schmuckli-Maurer J., et al. Expression analysis of the Theileria parva subtelomere-encoded variable secreted protein gene family. PLoS ONE 2009, 4:e4839.
96. Barry J.D., et al. Why are parasite contingency genes often associated with telomeres?. Int. J. Parasitol. 2003, 33:29-45.
97. Oura C.A., et al. Infection of bovine cells by the protozoan parasite Theileria annulata modulates expression of the ISGylation system. Cell. Microbiol. 2006, 8:276-288.
98. 2-terminal kinase/c-Jun signaling promotes survival and metastasis of B lymphocytes transformed by Theileria. Cancer Res. 2006, 66:6105-6110.
99. Vogelstein B., et al. Cancer genome landscapes. Science 2013, 339:1546-1558.